Class information for:
Level 1: ZEBRAFISH//UNITE MACROPHAGES DEV IMMUNITE//MOL CELLULAR PHARMACOL PHARMACOGEN PHARM

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
8021 1226 50.5 89%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1072 9457 ELECTRIC FISH//ELECTRIC ORGAN DISCHARGE//LATERAL LINE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ZEBRAFISH Journal 10 16% 5% 61
2 UNITE MACROPHAGES DEV IMMUNITE Address 8 62% 1% 8
3 MOL CELLULAR PHARMACOL PHARMACOGEN PHARM Address 5 50% 1% 7
4 STEM CELL PROGRAMHEMATOL ONCOL PROGRAM Address 4 75% 0% 3
5 STEM CELL PROGRAM HEMATOL ONCOL Address 3 57% 0% 4
6 TRANSFARLAND Address 3 57% 0% 4
7 UNITE MACROPHAGES DEV IMMUN Address 3 45% 0% 5
8 ZEBRAFISH MODELING DRUG SCREENING HUMAN Address 3 50% 0% 4
9 MRC DEV BIOMED GENET Address 3 16% 1% 16
10 CARLOTA SALDANHA Address 3 60% 0% 3

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
LCSH search Wikipedia search
1 BILIARY DEVELOPMENT 2 67% 0% 2 Search BILIARY+DEVELOPMENT Search BILIARY+DEVELOPMENT
2 MPX 2 67% 0% 2 Search MPX Search MPX
3 CHEMICAL SCREEN 2 26% 0% 5 Search CHEMICAL+SCREEN Search CHEMICAL+SCREEN
4 PRIMITIVE HEMATOPOIESIS 1 31% 0% 4 Search PRIMITIVE+HEMATOPOIESIS Search PRIMITIVE+HEMATOPOIESIS
5 DEYOLKING 1 100% 0% 2 Search DEYOLKING Search DEYOLKING
6 ENDODERM FORMATION 1 50% 0% 2 Search ENDODERM+FORMATION Search ENDODERM+FORMATION
7 IN VIVO DRUG DISCOVERY 1 100% 0% 2 Search IN+VIVO+DRUG+DISCOVERY Search IN+VIVO+DRUG+DISCOVERY
8 LEUKOCYTE BIOLOGY 1 100% 0% 2 Search LEUKOCYTE+BIOLOGY Search LEUKOCYTE+BIOLOGY
9 NETWORK PATHWAY 1 50% 0% 2 Search NETWORK+PATHWAY Search NETWORK+PATHWAY
10 PRIMITIVE AND DEFINITIVE HEMATOPOIESIS 1 100% 0% 2 Search PRIMITIVE+AND+DEFINITIVE+HEMATOPOIESIS Search PRIMITIVE+AND+DEFINITIVE+HEMATOPOIESIS

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 TRANSGENIC ZEBRAFISH 94 32% 20% 247
2 REGULATED TRANSGENIC ZEBRAFISH 32 80% 2% 20
3 EXPOSURE ROUTES 27 70% 2% 23
4 EARLY MACROPHAGES 24 60% 2% 26
5 MYELOID SPECIFIC EXPRESSION 23 79% 1% 15
6 CAUSES GENOME INSTABILITY 19 71% 1% 15
7 CLOCHE 16 51% 2% 23
8 CLONAL ZEBRAFISH 14 100% 1% 7
9 ANTIANGIOGENIC COMPOUNDS 11 78% 1% 7
10 DIFFERENT DEVELOPMENTAL STAGES 10 28% 2% 30

Journals



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ZEBRAFISH 10 16% 5% 61

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
15 years of zebrafish chemical screening 2015 2 68 40%
Macrophage-pathogen interactions in infectious diseases: new therapeutic insights from the zebrafish host model 2014 12 116 41%
Animal models of human disease: zebrafish swim into view 2007 577 110 38%
Zebrafish cancer: the state of the art and the path forward 2013 33 109 55%
Zebrafish: A New Companion for Translational Research in Oncology 2015 1 51 53%
Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era 2014 5 90 64%
Real-time imaging and genetic dissection of host-microbe interactions in zebrafish 2014 4 83 63%
Host-microbe interactions in the developing zebrafish 2010 74 99 45%
Host-Pathogen Interactions Made Transparent with the Zebrafish Model 2011 61 190 39%
Zebrafish and Streptococcal Infections 2015 1 69 33%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 UNITE MACROPHAGES DEV IMMUNITE 8 62% 0.7% 8
2 MOL CELLULAR PHARMACOL PHARMACOGEN PHARM 5 50% 0.6% 7
3 STEM CELL PROGRAMHEMATOL ONCOL PROGRAM 4 75% 0.2% 3
4 STEM CELL PROGRAM HEMATOL ONCOL 3 57% 0.3% 4
5 TRANSFARLAND 3 57% 0.3% 4
6 UNITE MACROPHAGES DEV IMMUN 3 45% 0.4% 5
7 ZEBRAFISH MODELING DRUG SCREENING HUMAN 3 50% 0.3% 4
8 MRC DEV BIOMED GENET 3 16% 1.3% 16
9 CARLOTA SALDANHA 3 60% 0.2% 3
10 ENDOTHELIAL MOL BIOL 3 60% 0.2% 3

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000208218 BOZOZOK//EPIBOLY//NO TAIL
2 0.0000168548 ZEBRAFISH NEUROSCI CONSORTIUM//MORFOL CIENCIAS FISIOL//ZNRC
3 0.0000108151 FUNDULUS HETEROCLITUS//BLUE SAC DISEASE//ELIZABETH RIVER
4 0.0000096174 HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS
5 0.0000090619 DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION
6 0.0000079505 CARDIAC LOOPING//LEFT ATRIAL LIGATION//EMBRYONIC CIRCULATION
7 0.0000074191 MAUTHNER CELL//MAUTHNER//MAUTHNER NEURON
8 0.0000059040 COMFREY//SYMPHYTUM HERB EXTRACT//BORC IBST
9 0.0000058470 SCOTTISH FISH IMMUNOL//LIPOPOLYSACCHARIDE INDUCED TNF ALPHA FACTOR//LITAF
10 0.0000051478 INTEGRATED BIOSCI 102//WORLDS MEDAKA AQUARIUM//NOMORHAMPHUS